))
The Field of Blood Cancers: How Have We Evolved
Manage episode 507334036 series 3393216
Baptist Health에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Baptist Health 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In this episode of Doc to Doc, we explore groundbreaking advances in the treatment of blood cancers with two of the field’s leading experts:
Dr. Guenther Koehne, Deputy Director and Chief of Blood and Marrow Transplant, Hematologic Oncology and Benign Hematology, and Dr. Firas El Chaer, Chief of Leukemia Services and Medical Director of Infusion — both from Baptist Health Miami Cancer Institute.
From precision-targeted therapies and measurable residual disease (MRD) to cutting-edge immunotherapies like (CAR) T-cell therapy, BiTEs, and NK-cell approaches — we cover the evolving tools that are reshaping treatment protocols across leukemia, myeloma, MDS, and lymphoma.
Topics Covered:
✅ MRD-guided treatment decisions
✅ Overcoming drug resistance with combination strategies
✅ Targeted therapies for actionable mutations
✅ The expanding role of CAR T, BiTEs, and NK cells
✅ Clinical application and access at Baptist Health
If you're an oncologist, hematologist, or transplant specialist navigating the complexity of hematologic malignancies — this conversation will help sharpen your clinical edge.
🔔 Subscribe for more expert insights: @BaptistHealthSF
📍 Learn more at MiamiCancerInstitute.com
30 에피소드
공유
